| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Ajanta Pharma Limited (NSE: AJANTPHARM)
AJANTPHARM Technical Analysis
3
| As on 25th Jan 2022 AJANTPHARM Share Price closed @ 2181.30 and we RECOMMEND Buy for LONG-TERM with Stoploss of 2066.24 & Buy for SHORT-TERM with Stoploss of 2162.72 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AJANTPHARM Share Price
| Open | 2104.10 | Change | Price | % |
| High | 2194.40 | 1 Day | 50.75 | 2.38 |
| Low | 2076.00 | 1 Week | -103.30 | -4.52 |
| Close | 2181.30 | 1 Month | 58.60 | 2.76 |
| Volume | 30898 | 1 Year | 422.35 | 24.01 |
| 52 Week High 2435.00 | 52 Week Low 1660.00 | ||||
NSE INDIA Most Active Stocks
| IDEA | 11.30 | 3.20% |
| VISESHINFO | 1.55 | 3.33% |
| JPPOWER | 9.05 | 2.84% |
| SUZLON | 11.00 | -0.90% |
| ZOMATO | 100.45 | 9.96% |
| YESBANK | 13.60 | 1.12% |
| BANKBARODA | 98.50 | 6.37% |
| PNB | 39.40 | 3.68% |
| ALOKINDS | 29.70 | 2.77% |
| INVENTURE | 5.45 | -4.39% |
NSE INDIA Top Gainers Stocks
| SALONA | 327.00 | 20.00% |
| SHARDACROP | 525.35 | 20.00% |
| AMBICAAGAR | 34.05 | 18.85% |
| PRESSMN | 48.65 | 16.67% |
| CORALFINAC | 49.85 | 14.60% |
| TRITURBINE | 214.30 | 14.42% |
| OMAXE | 93.10 | 13.95% |
| ARMANFIN | 792.95 | 13.76% |
| ORBTEXP | 100.00 | 13.44% |
| BIL | 304.25 | 12.31% |
NSE INDIA Top Losers Stocks
| AJANTPHARM Daily Charts |
AJANTPHARM Intraday Charts |
Whats New @ Bazaartrend |
AJANTPHARM Free Analysis |
|
|
AJANTPHARM Important Levels Intraday
| RESISTANCE | 2409.46 |
| RESISTANCE | 2336.29 |
| RESISTANCE | 2291.06 |
| RESISTANCE | 2245.83 |
| SUPPORT | 2116.77 |
| SUPPORT | 2071.54 |
| SUPPORT | 2026.31 |
| SUPPORT | 1953.14 |
AJANTPHARM Target for Month January
| 4th UP TARGET | 2832.73 |
| 3rd UP TARGET | 2641.21 |
| 2nd UP TARGET | 2522.83 |
| 1st UP TARGET | 2404.45 |
| 1st DOWN TARGET | 2066.65 |
| 2nd DOWN TARGET | 1948.27 |
| 3rd DOWN TARGET | 1829.89 |
| 4th DOWN TARGET | 1638.37 |
AJANTPHARM Weekly Target
| 4th UP TARGET | 2674.60 |
| 3rd UP TARGET | 2526.87 |
| 2nd UP TARGET | 2435.55 |
| 1st UP TARGET | 2344.23 |
| 1st DOWN TARGET | 2083.67 |
| 2nd DOWN TARGET | 1992.35 |
| 3rd DOWN TARGET | 1901.03 |
| 4th DOWN TARGET | 1753.30 |
AJANTPHARM Target for Year 2022
| 4th UP TARGET | 3777.15 |
| 3rd UP TARGET | 3282.75 |
| 2nd UP TARGET | 2977.15 |
| 1st UP TARGET | 2671.55 |
| 1st DOWN TARGET | 1799.55 |
| 2nd DOWN TARGET | 1493.95 |
| 3rd DOWN TARGET | 1188.35 |
| 4th DOWN TARGET | 693.95 |
Ajanta Pharma Limited ( NSE INDIA Symbol : AJANTPHARM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AJANTPHARM Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is 37.98 | Sideways | |
| MFI (14) | MFI is 39.93 | Sideways | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is -70.90 | Sideways | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 1425.63 | |
| 10 Day Avg Volume | Traded 17.25 % More then 10 Day Average Volume | ||
AJANTPHARM Other Details
| Segment | EQ | |
| Market Capital | 182067691520.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > | |
AJANTPHARM Address
 |
||
AJANTPHARM Latest News
AJANTPHARM Business Profile
Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets finished dosages. The company markets and serves various therapeutic segments, such as anti-biotic, anti-malarial, anti-diabetic, cardiology, gynecology, pediatric, respiratory and general health products, dermatology, ophthalmology, and pain management areas. It also provides multivitamins, antibiotics, eye drops, cough syrups, etc. The company serves in India, Africa, rest of Asia, the United States, and internationally. It supplies its products to government bodies, including armed forces, government hospitals, canteens, stores department, etc. The company was founded in 1973 and is headquartered in Mumbai, India. Address: Ajanta House, Mumbai, India, 400067
© 2005-2021 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service